Effect of Kuntai Capsule Combined with Levofloxacin in the Treatment of Chronic Pelvic Inflammatory Disease
Objective:To investigate the effect of Kuntai capsule combined with levofloxacin in the treatment of chronic pelvic inflammatory disease and its effect on inflammatory indexes and ovarian hemodynamics.Methods:From January 2019 to October 2022,62 patients with chronic pelvic inflammatory disease diagnosed and treated in our hospital were selected.According to the principle of 1∶1 parallel control,the patients were divided into combined group and reference group,with 31 patients in each group.The reference group was treated with levofloxacin,and the combined group was treated with Kuntai capsule on the basis of the reference group.The clinical efficacy,inflammatory indexes and ovarian hemodynamic changes were compared between the two groups.Results:After treatment,the total effective rate of the combined group(100.00%)was higher than that of the reference group(87.09%)(P<0.05);the levels of IL-1β,IL-6,RI and PI in the combined group were lower than those in the reference group(P<0.05).The scores of each dimension of quality of life in the combined group were higher than those in the reference group(P<0.05).Conclusion:Kuntai capsule combined with levofloxacin can improve the clinical efficacy of patients with chronic pelvic inflammatory disease,inhibit the expression of inflammatory factors,improve ovarian hemodynamics,and improve the quality of life of patients.
NETL
NSTL
万方数据
